Artificial Embolization Device Downclassification Supported By Panel
Artificial embolization devices for neurological use should be downclassified to Class II, FDA's Neurological Devices Panel agreed at a June 12 meeting in Rockville, Maryland.
Artificial embolization devices for neurological use should be downclassified to Class II, FDA's Neurological Devices Panel agreed at a June 12 meeting in Rockville, Maryland.